Clinical Trials Browser

Active not recruiting × Interventional × Blood Specimen Collection × Clear all

NCT02453620 2026-03-18

Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer

Phase 1 Active not recruiting

BreastOther solid neoplasm

Anatomic Stage III Breast Cancer AJCC v8

NCT02867033 2026-03-18

ALTITUDES

Phase NA Active not recruiting

Desmoid Tumors

NCT04454528 2026-03-10

BreastVAX

Phase 1/2 Active not recruiting

Breast Neoplasms

NCT03842696 2026-01-27

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

Phase 1/2 Active not recruiting

LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Graft vs Host Disease, Hematologic Diseases, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT03875690 2026-01-20

CORTIFRENCH

Phase 3 Active not recruiting

Elective Surgery for Any Digestive Cancer

NCT03465618 2026-01-07

A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors

Phase 1 Active not recruiting

Brain Neoplasms, Pituitary Neoplasms

NCT03955978 2026-01-06

TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer

Phase 1 Active not recruiting

Endometrial Neoplasms

NCT01991379 2025-12-04

MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Phase 1/2 Active not recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT04412629 2025-11-24

Cabozantinib in High Grade Neuroendocrine Neoplasms

Phase 2 Active not recruiting

High Grade Neuroendocrine Neoplasms

NCT03731845 2025-11-20

ESIGON

Phase NA Active not recruiting

BreastGynecologic

Breast Neoplasms, Primary Ovarian Insufficiency

NCT04067726 2025-10-16

TRIDENT

Phase 2 Active not recruiting

Breast Neoplasms

NCT03739775 2025-09-15

CIRCA-HPV

Phase NA Active not recruiting

HPV Positive Pelvic Cancer

NCT05091190 2025-09-11

MADMAS

Phase NA Active not recruiting

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms

NCT05011188 2025-08-27

FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer

Phase 1/2 Active not recruiting

Prostatic Neoplasms

NCT04046575 2025-07-11

Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer

Phase 1 Active not recruiting

Gastrointestinal

Esophageal Neoplasms

NCT03984318 2025-06-26

PREMIS

Phase NA Active not recruiting

Neoplasms

NCT02597738 2025-06-19

A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine

Phase NA Active not recruiting

Head & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms

NCT04331067 2025-04-23

Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer

Phase 1/2 Active not recruiting

15 enrolled 12 charts

Triple Negative Breast Neoplasms

NCT03252717 2025-04-02

BIORISE

Phase NA Active not recruiting

Breast Neoplasms

NCT05953883 2025-03-04

PROGENITOR

Phase NA Active not recruiting

Ovarian Neoplasms

NCT03375437 2024-08-26

RNASARC

Phase NA Active not recruiting

Neoplasm Metastasis, Sarcoma

NCT02068196 2023-03-24

Ipi4

Phase 4 Active not recruiting

Melanoma, Neoplasms